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Polyethylene Glycol containing ROMPolymers for the Modification of NeuroProtective Hemoglobin

An Honors Thesis submitted in partial fulfillment of the requirements for Honors in
Chemistry
By
Andrea Lindsey McCollum
Under the mentorship of Dr. Hans-Joerg Schanz
ABSTRACT
Polyethylene glycol (PEG) has shown the ability to improve compatibility when
used in combination with cell-free hemoglobin in the treatment of traumatic brain
injuries.

It has been demonstrated that the covalently bonded PEG increases the

hydrodynamic radius of the hemoglobin and hence generates a physical barrier while
slowing down the oxygen delivery of the strongly oxidative hemoglobin. In this context,
I have been working on the development of synthetic pathways to incorporate PEG into
monomers and polymers through both direct modification of (7-oxa)norbornene
derivatives and post polymerization modification. Starting from the (7-oxa)norbornene
anhydride derivatives, we have developed pathways to cationic and uncharged monomers
which can be polymerized via Ring Opening Metathesis Polymerization (ROMP) using
Grubbs 1st and 3rd generation-type Ru-alkylidene complexes.

These complexes are

known to produce ROMPolymers with high molecular weight control. In this context, we
also developed a chain transfer agent to introduce a functional end group into the polymer
which will enable the covalent binding of the polymer to the hemoglobin protein.
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INTRODUCTION
A life essential protein of the human body is found in red blood cells, the
hemoglobin. The hemoglobin primarily functions to collect oxygen from the lungs and
distribute it to other tissues throughout the body. The hemoglobin protein is unique in
that it can be isolated from red blood cells and not lose functionality; the protein
maintains its full oxygen binding capacities and properties making it an object of focus as
a therapeutic oxygen delivery system. The isolated hemoglobin protein is dubbed cellfree hemoglobin or free hemoglobin. Over the past decade, much time and research
efforts have been dedicated towards the development of using cell-free hemoglobin for
medicinal purposes. As of now, three cell-free hemoglobin based oxygen carrier (HBOC)
products have been used in human trials for the treatment of traumatic brain injuries
(TBI). Unfortunately, these HBOC products have not been approved by the FDA due to
the side effects.
Every nine seconds, a human being sustains a traumatic brain injury (TBI). TBI are
serious and widespread.

The mortality rate associated with TBI increases when

complicated by a secondary issues i.e. hemorrhagic shock, encephalitis, hypotension (low
blood pressure). Hypotension results in less blood and oxygen flowing to the tissues
throughout the body. Patients with TBI are extremely susceptible to hypotension; damage
to the neural network is due to the lack of proper oxygen circulation to effected areas.
This establishes a crucial need for modified HBOC products as part of a treatment which
restores blood pressure and oxygen delivery to the site of the TBI.
As previously mentioned, no HBOC product has been approved by the FDA for the
treatment of traumatic brain injuries. The problem with current HBOC products is the
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toxicity of reactive oxygen species (ROS) produced when the HBOC is introduced to the
body. In this context, HBOC products bind oxygen as effectively as red blood cells;
however, when the hemoglobin is removed from the cell, it loses its ability to detoxify
the superoxide radical species. The new generation of HBOC products will, in theory, be
able to bind oxygen while quenching the toxic radical as a result of premature oxygen
release. A possible candidate for this is polynitroxyl pegylated hemoglobin (PNPH).1-6
PNPH has demonstrated a lower toxicity for in vitro and in vivo models. These covalently
attached modifications contain an antioxidant to prevent ROS formation. After the
antioxidant is added to the hemoglobin, multiple polyethylene glycol chains are tethered
to the hemoglobin in order to increase the size and half-life of the HBOC. The current
synthetic methods are extensive, not very efficient and expensive; improving the current
procedure should improve the practicality and marketability of using HBOC products to
reverse TBI.7-8
In polymer synthesis, a powerful tool has been growing in popularity over the past
few decades: ring opening metathesis polymerization (ROMP).

9-11

ROMP can be

conducted at moderate temperatures and the Ru-alkylidene complexes are compatible
with many sensitive functional groups. ROMP is an ideal technique for the synthesis of
(co)polymers with sensitive biological functional groups as present in our targeted
materials. Another ideal feature of ROMP is that the polymerization proceeds
continuously until addition of a terminating agent; hence, the polymerization is “living”.
This aspect allows both the molecular weight and physical properties of polymers to be
regulated with a high amount of precision with the use of an appropriate catalyst. The
combination of these features makes ROMP the most suitable technique for the project.
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DISCUSSION AND RESULTS
Figure 1: Ruthenium based catalysts used for controlled polymerization of Pegylated ROM monomers

The two catalyst shown in Figure 1 are Grubbs 1st (GC1) and 3rd (GC3)
generation-type ruthenium-alkylidene complexes used for controlled Ring Opening
Metathesis Polymerization (ROMP) due to their ability to produce ROMPolymers with
high molecular weight control. The catalyst is available in large quantities and was
developed in the Schanz laboratories12. Both catalysts are inert towards sensitive
functional groups while being highly active. Both catalysts are capable of controlled
ROMP (the molecular weight can be controlled) based on their fast initiation rates. (7oxa)norbornene derivatives9-13 are very good monomers for this project because of the
low tendency to engage in secondary metathesis reactions such as internal chain transfer
via ring closing metathesis;14-17 they are highly capable monomers for controlled ROMP
due to their high ring strain. We are confident that the combination of monomers and
catalysts will enable us to produce multifunctional polymers to attach covalently to cell
free hemoglobin.
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The first generation catalyst GC1 is a much slower propagator than the third
generation catalyst GC3. Hence, ROMP will require longer polymerization time;
however, GCI is less prone to decompose when conditions are not ideal. GC3 is a faster
propagator, but tends to decompose under conditions that are not ideal. The overall
advantage of using these catalysts is the ability to control the molecular weight due to
their fast initiation compared to the propagation. GC1 and GC3 are very efficient
initiators, so all of the polymer chains should be about the same length under the
assumption that the rate of propagation is stable.

ROMP requires a terminating agent to end the polymerization; otherwise, the
polymerization will continue and cross linking can occur. Bromoacetyl Bromide 1
reacted with the Z-diol 2 with base to yield diester 3. This product can, when added,
attach to the end of the polymer chain while terminating the polymerization. The attached
bromo end group can make the covalent link to the lysine amino group of the
hemoglobin.
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Synthesis of Cationic, Water Soluble Monomer species.

For our first monomer, we started with commercially available compound 4,
polyethylene glycol (PEG). We synthesized the iodide via the tosylate intermediate 5 in
overall 82.5% yield. The PEG-Iodide 6 was produced at 67.5% yield.

7-oxanorbornene derivative 9 was synthesized with an ancillary amino group.
Ethylene Diamine 7 reacted with the carboxylic anhydride 8 (produced in a known
reaction10according to Scheme 3) to obtain the imide monomer 9.

The cationic monomer 10 is produced by the addition of PEG-Iodide 6 to the dimethyl amino group in monomer 9. This monomer has a counter iodide anion. In the
context of ROMP, the iodides can substitute the chlorines on the ruthenium catalyst..
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Iodide is a larger ligand than chloride. This has two consequences. The larger iodide
ligands cause the initiation stage of the catalyst to accelerate. The larger ligands
destabilizes the leaving ligand at the catalyst due to steric hinderance. However, this
steric hindrance also slows the propagation stage. These larger ligands can hinder the
swing through mechanism that controls the propagation. Overall, the iodide causes faster
initiation which helps have a more controlled molecular weight, but causes faster catalyst
degradation which is linked to the initiation rates.
Figure 2: 1H NMR of cationic PEG-monomer, 250 MHz, CDCl3

The 1H NMR spectrum of the water soluble, cationic monomer 9 (Fig.2) exhibits
its furthest downfield peak (1) for the two hydrogen atoms bonded to the alkene in the
bicyclic ring system. The second farthest downfield peak (2) is the signal for the two
hydrogen atoms on the oxo-bridged carbon atoms. The largest peak (5) includes the
protons that make up the PEG chain and overlap with the protons between the nitrogen
atoms. Peak 4 consists of the protons on the two equivalent methyl groups on the
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ammonium nitrogen atoms. The ratio of 2:32 between hydrogen atoms (1) and (5) is
indicative of 16 CH2 groups in the PEG, the expected amount for a PEG with the
molecular weight of 400 g/mol as used in this monomer.

Monomer 10 was polymerized Grubbs 3rd generation catalyst GC3. The reaction
took place under inert gas in methylene chloride. With 5% catalyst loading,
polymerization ran for one hour, and chain transfer reagent 3 added after the hour
(Scheme 5).
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Figure 3: 1H NMR spectrum (CDCl3, 250 MHz) of the polymerization mixture after addition of terminating agent and
removal of solvent.

The 1H NMR spectrum (Figure 3), indicates an incomplete polymerization
(~75%) by exhibiting signals for both monomer and polymer at with integrations of 1:3
monomer to polymer. There are a few possibilities as to why there was incomplete
conversion. The concentration of the iodide may have inhibited the reaction from going
to completion; iodide is known to reduce propagation rates meaning the one hour reaction
time may have been too short. Another possibility is that the ruthenium catalyst has
degraded in polar solvent needed for the cationic monomer. In this case, longer reaction
times will not change conversion and a low molecular weight control will also be
observed. Due to the unexpected problems with the cationic monomer 10, we decided to
shift our research focus to making neutral pegylated monomers.
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Synthesis of Neutrally Charged Monomer Species.

The first neutrally charged pegylated monomer 7 is produced from the direct
esterification of the carboxylic anhydride 3 with polyethylene glycol 4. The reaction
requires no solvent; thionyl chloride (0.5 mL) is added and the solution stirred for 24
hours. Over the 24 hours, the solution turns grey in color. The workup involves an
extraction with methylene chloride and bicarbonate solution to remove excess PEG-OH.
Figure 4: 1H NMR spectrum (CDCl3, 250 MHz) of the7- oxa-norbornene diester monomer
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The 1H NMR spectrum of 7 exhibits the expected signals 1,2,3 for the
(oxa)norbornene fragment and 5 for the PEG; the integration of 1:40 is approximately the
expected ratio of 2:64 to but may also indicate some PEG-OH contamination in the
monomer.

The ROMPolymerization (Scheme 7) of monomer 14 was performed in
methylene chloride and 5% catalyst loading. The solution is mixed for an hour. The
terminating agent (ethyl vinyl ether) was added and the solvent is removed.
1

Figure 5: H NMR spectrum (CDCl , 250 MHz) of the ROMPolymerization of 7- oxa-norbornene diester monomer
3
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This polymerization appeared to have reached a high conversion based on the 1H
spectrum (Fig. 4). The monomeric peak is virtually nonexistent. The polymer peak is
clearly defined. For further confirmation of the homopolymer, gel permeation
chromatography (GPC) is used. The purpose of the GPC is to determine the molecular
weight and molecular weight distribution. Due to the use of Grubbs 1st and 3rd catalyst
which is capable of controlled ROMP, the molecular weight distribution should be
relatively narrow. The polymer has a theoretical molecular weight 19,000 g/mol.
Figure 5: GPC analysis of PEG- diester Homopolymer
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The data given by the GPC tells us that the “polymer” has a molecular weight
distribution significantly smaller than 12,500g/mol. This suggests the presence of an
oligomer (a few repeating units) instead of a polymer. There are two reasons for low
degrees of polymerization. Chain transfer would cause an increased number of polymer
chains growing causing a decrease in the average molecular weight. The polymerization
may have just needed more time to complete the polymerization.

PEG 4 was deprotonated yielding the intermediate 17. Addition of propargyl
bromide renders propargyl PEG 18. Propargyl PEG 18 has a reactive alkynyl group,
which can be used for post polymerization modification.

The exo-carboxylic anhydride 8 was reacted with propargyl alcohol yielding
monomer 19. The thionyl chloride opens the bicyclic ring making a diester. We intend to
modify this monomer via click reaction with respective functional azides. The
modifications have not been started as of yet.
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In similar fashion, exo-carboxylic anhydride 8 was reacted with bromoethanol
yielding monomer 20. The thionyl chloride opens the bicyclic ring making a diester. This
monomer can be modified by converting it into the diazide monomer 21. This would be
the complementary approach to the “click” introduction of the functional groups.
Future Outlook

The ultimate goal of the research is to make copolymers containing PEG and TEMPO.
Polymerization of neutral PEG and TEMPO monomers would yield the copolymers 23

and 24 (Scheme 11). The copolymerization of two monomeric units, pegylated diester 14
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and TEMPO monomer 22, can yield two different types of polymers. The first is
statistical copolymer 23. This polymer is achieved by polymerizing monomers 14 and 22
at the same time, meaning you get a polymer with a statistical mix of TEMPO and PEG
monomers. The block copolymer 24 is achieved by sequentially polymerizing monomer
14 and adding monomer 22 after all of monomer 14 is polymerized. This polymer should
have literally a block of polymer consisting of only diester monomeric units and a block
consisting of only TEMPO monomeric units. Unfortunately, these polymerizations were
attempted twice and were unsuccessful in both cases.

The synthesis laid out in Scheme 12 is a proposed multistep procedure to generate
a monomer 28 that can be modified to incorporate PEG i.e. monomer 2 or other
functionalities. Ethylene Diamine 25 will aminate the anhydride to produce monomer 26.
The addition of bromoacetyl bromide renders 27. The bromine acts as a good leaving
group allowing the addition of the azide. PEG can be incorporated via click reaction
using a copper catalyst to change an azide to a triazole. The advantage of using the click
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reaction is that it is a well-known, very reliable and quantitative reaction that forms no
additional side products. Click is also a very fast reaction that uses an inexpensive Cu(I)
catalyst and is not sensitive to functional groups. Propargyl PEG 18 could be attached to
monomer 28 either before or after polymerization to render the Pegylated monomer 29 or
the corresponding polymer.

The imide monomer 26 was initially thought to be isolated; however, a dimer 31
was formed. However, monomer 26 is observed in the NMR. Current work is being done
to isolate product 26 and form a protocol. For the synthesis, ethylene diamine solution is
toluene is made; the anhydride is added slowly while heating the solution. The solution
needs to be gently heated for 24 hours, then phosphoric acid is added and the solution
refluxed for 72 hours. The reaction needs to be monitored to find when our product of
interest is formed. If the reaction is not given enough time to react, then the unsymmetric

16 | P a g e

amide product 30 is dominant. If the reaction goes for too long, then a dimer 31 is
formed. Isolation of monomer 26 is crucial.
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EXPERIMENTAL

Diester 3:
Cis-2-Butene-1,4-diol 2 (0.3397g) was measured into a vial. Triethylamine (NEt3)
(1.0027g) was measured into a separate vial. Methylene chloride (20 mL) was poured
into a round bottom flask. The flask as placed in an ice bath; NEt3 and 2 were quickly
pipetted into the chilled flask; the flask was sealed. The Bromoacetyl Bromide 1 was
measured into a vial in the nitrogen dry box and removed from the inert gas atmosphere.
Compound 1 was added to the flask and stirred for 1 hour. After 1 hour, an extraction
was done. The first wash was with (0.1 M) phosphoric acid to remove excess
Triethylamine. The second wash was with a (0.1M) bicarbonate solution to neutralize any
acid left over. The organic phase was dried over sodium sulfate and the solvent removed.
To purify the compound, a flash column was used. Ethyl acetate was used as the running
solvent. The solvent of the filtrate was removed and dried in the vacuum oven.
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PEG-Tosylate 5:
10 grams of Polyethylene Glycol (PEG-400) 4 was added to a 500mL round
bottom flask. Methylene chloride was added as the solvent. 1 molar equivalent of tosyl
chloride (4.766 g) was added next. The solution stirred for 5 minutes to dissolve the
starter. Last, 1 molar equivalent of Triethylamine (0.303g) was added; the solution was
stirred for 6 days. An extraction was done as a workup. The first wash was with (0.1 M)
phosphoric acid. The second wash was with a (0.1M) bicarbonate solution; the separation
settled for 1 hour. The last wash was with water. The organic phase was separated, dried
over sodium sulfate and the solvent removed. The total yield for the tosylate intermediate
5 was 82. 5%.
PEG-Iodide 6:
PEG-tosylate 5 (12.372 g) was dissolved in acetone (40 mL). 2 molar equivalents
of Potassium Iodide was added to the solution and stirred. Within the first 30 minutes of
stirring, a solid formed. More acetone was added and the slurry was refluxed overnight.
The refluxed slurry was filtered removing excess potassium iodide. The filtrate was a
deep red. The solvent was replaced with DCM and an extraction was done. The first wash
was with (0.1M) sodium sulfate and (0.1M) bicarbonate solution. The organic phase was
greatly decolorized producing a light yellow. The yield for producing PEG –Iodide 6 was
67.5%.
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Diemiethylamino Imide 9:
Exo-3,6-ep-oxy-1,2,3,6-tetrahydrophtalic anhydride 8 was added to a round
bottom flask in 1:1 MeOH/THF. The solution was stirred at 50°C; the N,N- Dimethyl
ethylenediamine 7 was added slowly to the solution. The solution stirred overnight. The
solvent was removed and replaced with MeOH. The flask was placed in the freezer to
yield white crystals. To get the remaining product, the methanol was removed and dried
in the vacuum oven. Ethanol (50 mL) and concentrated HCl (2mL) was added. Once the
precipitate was dissolved, the solution was removed to yield monomer 9.

Cationic, Water Soluble 10:
PEG-Iodide 6 (0.3797g) and monomer 9 (0.1758 g) were added to a round bottom
flask with acetone (20 mL) and refluxed for 3 hours. The reaction was incomplete. The
solution was refluxed for an additional 4 days. An extraction was done; the first wash was
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DCM/water. The second wash was with sodium thiosulfate. The last wash was with
water. The organic phase was dried over sodium sulfate yielding cationic monomer 10.

Cationic Polymer 11:
The PEGI-monomer 10 (0.3508 g) was added to a round bottom flask and placed
in the nitrogen dry box. The Grubbs third generation catalyst GC3 was added, and the
solution stirred for 30 minutes. The terminating agent Bromo-diester 3 was added; the
solution stirred for an hour. The solvent was removed and the product was dried.
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Diester Pegylated Norbornene derivative 15:
PEG-400 4 (5g) was weighed into a round bottom flask. The carbic anhydride 12
was weighed and placed in the flask. Thionyl chloride (3 mL) was added and the flask
stirred for 7 days. After 7 days, an extraction was done in two parts. The first wash was
with bicarbonate solution to remove acid produced during the reaction. The second wash
was with water. The bicarbonate wash separated for 1.5 hours. The second wash settled
for about 12 hours. Sodium chloride was added to each wash to expedite the process of
separation. The organic phase was dried over sodium sulfate and the solvent removed
yielding our product 15.
Diester Pegylated (7-oxa)norbornene derivative 14:
PEG-400 1 (5g) was weighed into a round bottom flask. The carboxylic anhydride
8 was weighed and placed in the flask. Thionyl chloride (3 mL) was added and the flask
stirred for 7 days. After 7 days, an extraction was done in two parts. The first wash was
with bicarbonate solution and the second wash was with water. The bicarbonate wash
separated for 1.5 hours. The second wash settled for about 12 hours. Sodium chloride was
added to each wash to expedite the process of separation. The organic phase was dried
over sodium sulfate and the solvent removed. Yielding our product 14.
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Neutrally Charged Polymer 16:

The pegylated diester monomer 14 was weighed into a vial and placed in the
nitrogen dry box. The catalyst was weighed into a small round bottom flask; 15 mL of
methylene chloride was added and the monomer 14 was added last. The solution
polymerized for an hour before the terminating agent (ethyl vinyl ether) was added. The
purification required a filtration. The methylene chloride was replaced by methanol.
Activated carbon was added to the solution and settled for 10 minutes. After that, the
solution was filtered through celite. A colorless filtrate was produced. The solvent was
removed and dried in the vacuum oven yielding polymer 16.

Propargyl PEG 18:
PEG 4 was weighed into a round bottom flask and brought into the nitrogen dry
box. The solvent tetrahydrofuran (THF) was added to the flask; the flask was removed
from the dry box. 1.5 molar equivalents of Sodium Hydride (60% dispersed in mineral
oil) was added to the solution. A condenser and bubbler were added to the apparatus; the
solution stirred for 24 hours. The intermediate PEG-hydride 17 was formed. 1.3 molar
equivalents of propargyl bromide (80% in toluene) was added to 17 and the solution
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refluxed for 4 days. The THF was replaced by methylene chloride. An extraction was
done with 3 water washes.

Diester Alkyne 19:
Exo-carboxylic anhydride 8 and propargyl alcohol were added to a round bottom
flask in a 1:5 molar ratio of anhydride to alcohol. Thionyl chloride was added and the
solution stirred for 24 hours. An extraction was done in three parts. The first wash was
with water/DCM. The second wash was with bicarbonate solution. For the third wash, the
organic solvent was replaced with ethyl acetate. The organic phase was dried over
sodium sulfate and the solvent replaced by 1:5 cyclohexane to t-butyl-methyl ether. The
solution was placed in the freezer to recrystallize. The liquid was decanted off yielding
pure white crystals of 19.
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Bromo Diester 20:
Exo-carboxylic anhydride 8 and bromoethanol were added to a round bottom
flask in a 1:5 molar ratio of anhydride to alcohol. Thionyl chloride was added and the
solution stirred for 24 hours. An extraction was done in three parts. The first wash was
with water/DCM. The second wash was with bicarbonate solution. For the third wash, the
organic solvent was replaced with ethyl acetate. The organic phase was dried over
sodium sulfate and the solvent replaced by t-butyl-methyl ether. The solution was placed
in the freezer. A precipitate formed and was filtered off of product 20.
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